Reminder: Corporate Access – Events: Barclays Hosted: Events at ASCO 2026

Research evidence excerpt

Reminder: Corporate Access – Events: Barclays Hosted: Events at ASCO 2026

elected member of the American Society for Clinical Investigation (ASCI) and a former

President of the Society for Melanoma Research.

Douglas K. Marks, MD, is the Director of the Clinical Trials Office, Perlmutter Cancer

Center, NYU Langone Hospital—Long Island, and an Associate Professor in the Department

of Medicine at NYU Grossman Long Island School of Medicine in New York City. He is a

Breast Cancer medical oncologist. He is an investigator on multiple clinical trials that are

evaluating the activity of newly developed therapeutic agents in breast cancer and other

solid malignancies. He has interest in immunotherapy and is currently a collaborator on

several translational research projects aimed at broadening the efficacy of immunotherapy

in breast cancer and other solid malignancies. Prior to entering clinical practice, he worked

in a lab using genomic and nongenomic pathology platforms to study the effects between

cancer therapeutics and the immune system. His research has been presented at the San

Antonio Breast Cancer Symposium—an international symposium focused on the treatment

of breast cancer—in addition to presentations at the American Association for Cancer

Research (AACR), the American Society of Clinical Oncology, the Society for Immunology of

Cancer, and at the Eastern Cooperative Oncology Group–American College of Radiology

Imaging Network Cancer Research Group meeting, as well as published in peer reviewed

journals.

Joshua K. Sabari, MD is an Assistant Professor of Medicine, Thoracic Medical Oncologist

and member of the Phase I Experimental Therapeutics Group in the Department of Medical

Oncology at New York University School of Medicine, NYU Langone Health Perlmutter